ZA200610644B - Oligonucleotides for cancer diagnosis - Google Patents
Oligonucleotides for cancer diagnosis Download PDFInfo
- Publication number
- ZA200610644B ZA200610644B ZA200610644A ZA200610644A ZA200610644B ZA 200610644 B ZA200610644 B ZA 200610644B ZA 200610644 A ZA200610644 A ZA 200610644A ZA 200610644 A ZA200610644 A ZA 200610644A ZA 200610644 B ZA200610644 B ZA 200610644B
- Authority
- ZA
- South Africa
- Prior art keywords
- cancer
- probes
- proteins
- genes
- sample
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title claims description 153
- 108091034117 Oligonucleotide Proteins 0.000 title claims description 151
- 201000011510 cancer Diseases 0.000 title claims description 122
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 title claims description 81
- 238000003745 diagnosis Methods 0.000 title claims description 22
- 108090000623 proteins and genes Proteins 0.000 claims description 270
- 239000000523 sample Substances 0.000 claims description 257
- 238000000034 method Methods 0.000 claims description 145
- 230000014509 gene expression Effects 0.000 claims description 108
- 210000004027 cell Anatomy 0.000 claims description 102
- 239000002299 complementary DNA Substances 0.000 claims description 70
- 108020004999 messenger RNA Proteins 0.000 claims description 64
- 102000004169 proteins and genes Human genes 0.000 claims description 57
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 53
- 229920001184 polypeptide Polymers 0.000 claims description 52
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 52
- 201000010099 disease Diseases 0.000 claims description 50
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 50
- 108020005187 Oligonucleotide Probes Proteins 0.000 claims description 48
- 239000002751 oligonucleotide probe Substances 0.000 claims description 48
- 238000012360 testing method Methods 0.000 claims description 45
- 230000000295 complement effect Effects 0.000 claims description 37
- 239000007787 solid Substances 0.000 claims description 37
- 238000011835 investigation Methods 0.000 claims description 22
- 238000012544 monitoring process Methods 0.000 claims description 21
- 206010006187 Breast cancer Diseases 0.000 claims description 20
- 208000026310 Breast neoplasm Diseases 0.000 claims description 20
- 102000002278 Ribosomal Proteins Human genes 0.000 claims description 20
- 108010000605 Ribosomal Proteins Proteins 0.000 claims description 20
- 210000001519 tissue Anatomy 0.000 claims description 18
- 230000014616 translation Effects 0.000 claims description 16
- 102000005962 receptors Human genes 0.000 claims description 15
- 108020003175 receptors Proteins 0.000 claims description 15
- 102100040247 Tumor necrosis factor Human genes 0.000 claims description 14
- 230000001105 regulatory effect Effects 0.000 claims description 13
- 230000002441 reversible effect Effects 0.000 claims description 12
- 238000013519 translation Methods 0.000 claims description 10
- 108020004414 DNA Proteins 0.000 claims description 9
- 230000028993 immune response Effects 0.000 claims description 9
- 230000004044 response Effects 0.000 claims description 9
- 210000001124 body fluid Anatomy 0.000 claims description 8
- 239000010839 body fluid Substances 0.000 claims description 8
- 108010077544 Chromatin Proteins 0.000 claims description 7
- 102000008857 Ferritin Human genes 0.000 claims description 7
- 108050000784 Ferritin Proteins 0.000 claims description 7
- 238000008416 Ferritin Methods 0.000 claims description 7
- 108010063738 Interleukins Proteins 0.000 claims description 7
- 102000015696 Interleukins Human genes 0.000 claims description 7
- 210000003483 chromatin Anatomy 0.000 claims description 7
- 230000005764 inhibitory process Effects 0.000 claims description 7
- 229940047122 interleukins Drugs 0.000 claims description 7
- 239000002699 waste material Substances 0.000 claims description 7
- 241000282414 Homo sapiens Species 0.000 claims description 6
- 102000001253 Protein Kinase Human genes 0.000 claims description 6
- 210000003719 b-lymphocyte Anatomy 0.000 claims description 6
- -1 protcosome subunits Proteins 0.000 claims description 6
- 108060006633 protein kinase Proteins 0.000 claims description 6
- 238000013518 transcription Methods 0.000 claims description 6
- 230000035897 transcription Effects 0.000 claims description 6
- 102000034286 G proteins Human genes 0.000 claims description 5
- 108091006027 G proteins Proteins 0.000 claims description 5
- 102000002812 Heat-Shock Proteins Human genes 0.000 claims description 5
- 108010004889 Heat-Shock Proteins Proteins 0.000 claims description 5
- 108010033040 Histones Proteins 0.000 claims description 5
- 206010021143 Hypoxia Diseases 0.000 claims description 5
- 108060003951 Immunoglobulin Proteins 0.000 claims description 5
- 230000033228 biological regulation Effects 0.000 claims description 5
- 238000002405 diagnostic procedure Methods 0.000 claims description 5
- 239000003623 enhancer Substances 0.000 claims description 5
- 230000007954 hypoxia Effects 0.000 claims description 5
- 102000018358 immunoglobulin Human genes 0.000 claims description 5
- 239000003112 inhibitor Substances 0.000 claims description 5
- 210000005259 peripheral blood Anatomy 0.000 claims description 5
- 239000011886 peripheral blood Substances 0.000 claims description 5
- 210000003705 ribosome Anatomy 0.000 claims description 5
- 102000014914 Carrier Proteins Human genes 0.000 claims description 4
- 102000011727 Caspases Human genes 0.000 claims description 4
- 108010076667 Caspases Proteins 0.000 claims description 4
- 102000003951 Erythropoietin Human genes 0.000 claims description 4
- 108090000394 Erythropoietin Proteins 0.000 claims description 4
- 102000002241 Eukaryotic Initiation Factors Human genes 0.000 claims description 4
- 108010014863 Eukaryotic Initiation Factors Proteins 0.000 claims description 4
- 102000043136 MAP kinase family Human genes 0.000 claims description 4
- 108091054455 MAP kinase family Proteins 0.000 claims description 4
- 241000124008 Mammalia Species 0.000 claims description 4
- 102000007456 Peroxiredoxin Human genes 0.000 claims description 4
- 102000019197 Superoxide Dismutase Human genes 0.000 claims description 4
- 108010012715 Superoxide dismutase Proteins 0.000 claims description 4
- 230000004913 activation Effects 0.000 claims description 4
- 108091008324 binding proteins Proteins 0.000 claims description 4
- 229940105423 erythropoietin Drugs 0.000 claims description 4
- 230000036542 oxidative stress Effects 0.000 claims description 4
- 108030002458 peroxiredoxin Proteins 0.000 claims description 4
- OXCMYAYHXIHQOA-UHFFFAOYSA-N potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Chemical compound [K+].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C2=N[N-]N=N2)C=C1 OXCMYAYHXIHQOA-UHFFFAOYSA-N 0.000 claims description 4
- 238000001243 protein synthesis Methods 0.000 claims description 4
- 102000005701 Calcium-Binding Proteins Human genes 0.000 claims description 3
- 108010045403 Calcium-Binding Proteins Proteins 0.000 claims description 3
- 102000016736 Cyclin Human genes 0.000 claims description 3
- 108050006400 Cyclin Proteins 0.000 claims description 3
- 102000004127 Cytokines Human genes 0.000 claims description 3
- 108090000695 Cytokines Proteins 0.000 claims description 3
- 102000000541 Defensins Human genes 0.000 claims description 3
- 108010002069 Defensins Proteins 0.000 claims description 3
- 102000018071 Immunoglobulin Fc Fragments Human genes 0.000 claims description 3
- 108010091135 Immunoglobulin Fc Fragments Proteins 0.000 claims description 3
- 108010050904 Interferons Proteins 0.000 claims description 3
- 102000014150 Interferons Human genes 0.000 claims description 3
- 206010033128 Ovarian cancer Diseases 0.000 claims description 3
- 206010061535 Ovarian neoplasm Diseases 0.000 claims description 3
- 108010044843 Peptide Initiation Factors Proteins 0.000 claims description 3
- 102000005877 Peptide Initiation Factors Human genes 0.000 claims description 3
- 108091023040 Transcription factor Proteins 0.000 claims description 3
- 102000040945 Transcription factor Human genes 0.000 claims description 3
- 102000018594 Tumour necrosis factor Human genes 0.000 claims description 3
- 108050007852 Tumour necrosis factor Proteins 0.000 claims description 3
- 210000000481 breast Anatomy 0.000 claims description 3
- 239000003102 growth factor Substances 0.000 claims description 3
- 229940079322 interferon Drugs 0.000 claims description 3
- ZIIUUSVHCHPIQD-UHFFFAOYSA-N 2,4,6-trimethyl-N-[3-(trifluoromethyl)phenyl]benzenesulfonamide Chemical compound CC1=CC(C)=CC(C)=C1S(=O)(=O)NC1=CC=CC(C(F)(F)F)=C1 ZIIUUSVHCHPIQD-UHFFFAOYSA-N 0.000 claims description 2
- KISWVXRQTGLFGD-UHFFFAOYSA-N 2-[[2-[[6-amino-2-[[2-[[2-[[5-amino-2-[[2-[[1-[2-[[6-amino-2-[(2,5-diamino-5-oxopentanoyl)amino]hexanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]amino]-3-hydroxypropanoyl]amino]-5-oxopentanoyl]amino]-5-(diaminomethylideneamino)p Chemical compound C1CCN(C(=O)C(CCCN=C(N)N)NC(=O)C(CCCCN)NC(=O)C(N)CCC(N)=O)C1C(=O)NC(CO)C(=O)NC(CCC(N)=O)C(=O)NC(CCCN=C(N)N)C(=O)NC(CO)C(=O)NC(CCCCN)C(=O)NC(C(=O)NC(CC(C)C)C(O)=O)CC1=CC=C(O)C=C1 KISWVXRQTGLFGD-UHFFFAOYSA-N 0.000 claims description 2
- 102100022600 40S ribosomal protein S3a Human genes 0.000 claims description 2
- 102100022406 60S ribosomal protein L10a Human genes 0.000 claims description 2
- 102100022289 60S ribosomal protein L13a Human genes 0.000 claims description 2
- 102100021690 60S ribosomal protein L18a Human genes 0.000 claims description 2
- 102100023247 60S ribosomal protein L23a Human genes 0.000 claims description 2
- 102100021927 60S ribosomal protein L27a Human genes 0.000 claims description 2
- 101710187898 60S ribosomal protein L28 Proteins 0.000 claims description 2
- 102100022276 60S ribosomal protein L35a Human genes 0.000 claims description 2
- 102100031002 60S ribosomal protein L36a Human genes 0.000 claims description 2
- 102100036126 60S ribosomal protein L37a Human genes 0.000 claims description 2
- 102100036630 60S ribosomal protein L7a Human genes 0.000 claims description 2
- 102000052866 Amino Acyl-tRNA Synthetases Human genes 0.000 claims description 2
- 108700028939 Amino Acyl-tRNA Synthetases Proteins 0.000 claims description 2
- 102100022014 Angiopoietin-1 receptor Human genes 0.000 claims description 2
- 102000006996 Aryldialkylphosphatase Human genes 0.000 claims description 2
- 108010008184 Aryldialkylphosphatase Proteins 0.000 claims description 2
- 102000000905 Cadherin Human genes 0.000 claims description 2
- 108050007957 Cadherin Proteins 0.000 claims description 2
- 102100035882 Catalase Human genes 0.000 claims description 2
- 108010053835 Catalase Proteins 0.000 claims description 2
- 102000016362 Catenins Human genes 0.000 claims description 2
- 108010067316 Catenins Proteins 0.000 claims description 2
- 102000005600 Cathepsins Human genes 0.000 claims description 2
- 108010084457 Cathepsins Proteins 0.000 claims description 2
- 108010012236 Chemokines Proteins 0.000 claims description 2
- 102000019034 Chemokines Human genes 0.000 claims description 2
- 206010009944 Colon cancer Diseases 0.000 claims description 2
- 108010058546 Cyclin D1 Proteins 0.000 claims description 2
- 108010015742 Cytochrome P-450 Enzyme System Proteins 0.000 claims description 2
- 102000003849 Cytochrome P450 Human genes 0.000 claims description 2
- 102220519085 Cytochrome P450 1A2_S18C_mutation Human genes 0.000 claims description 2
- 101710088194 Dehydrogenase Proteins 0.000 claims description 2
- 102000002045 Endothelin Human genes 0.000 claims description 2
- 108050009340 Endothelin Proteins 0.000 claims description 2
- 108010092408 Eosinophil Peroxidase Proteins 0.000 claims description 2
- 102100028471 Eosinophil peroxidase Human genes 0.000 claims description 2
- 108090000386 Fibroblast Growth Factor 1 Proteins 0.000 claims description 2
- 102100031706 Fibroblast growth factor 1 Human genes 0.000 claims description 2
- 201000003741 Gastrointestinal carcinoma Diseases 0.000 claims description 2
- 102000005731 Glucose-6-phosphate isomerase Human genes 0.000 claims description 2
- 108010070600 Glucose-6-phosphate isomerase Proteins 0.000 claims description 2
- 102000017278 Glutaredoxin Human genes 0.000 claims description 2
- 108050005205 Glutaredoxin Proteins 0.000 claims description 2
- 108010063907 Glutathione Reductase Proteins 0.000 claims description 2
- 102100036442 Glutathione reductase, mitochondrial Human genes 0.000 claims description 2
- 108010036164 Glutathione synthase Proteins 0.000 claims description 2
- 102100034294 Glutathione synthetase Human genes 0.000 claims description 2
- 102000005720 Glutathione transferase Human genes 0.000 claims description 2
- 108010070675 Glutathione transferase Proteins 0.000 claims description 2
- 102100029242 Hexokinase-2 Human genes 0.000 claims description 2
- 101710198385 Hexokinase-2 Proteins 0.000 claims description 2
- 102000006947 Histones Human genes 0.000 claims description 2
- 101000691550 Homo sapiens 39S ribosomal protein L13, mitochondrial Proteins 0.000 claims description 2
- 101000755323 Homo sapiens 60S ribosomal protein L10a Proteins 0.000 claims description 2
- 101000681240 Homo sapiens 60S ribosomal protein L13a Proteins 0.000 claims description 2
- 101000752293 Homo sapiens 60S ribosomal protein L18a Proteins 0.000 claims description 2
- 101001115494 Homo sapiens 60S ribosomal protein L23a Proteins 0.000 claims description 2
- 101001110988 Homo sapiens 60S ribosomal protein L35a Proteins 0.000 claims description 2
- 101001127203 Homo sapiens 60S ribosomal protein L36a Proteins 0.000 claims description 2
- 101001092424 Homo sapiens 60S ribosomal protein L37a Proteins 0.000 claims description 2
- 101000853243 Homo sapiens 60S ribosomal protein L7a Proteins 0.000 claims description 2
- 101000753291 Homo sapiens Angiopoietin-1 receptor Proteins 0.000 claims description 2
- 101000882390 Homo sapiens Histone acetyltransferase p300 Proteins 0.000 claims description 2
- 101001134134 Homo sapiens Oxidation resistance protein 1 Proteins 0.000 claims description 2
- 101000980827 Homo sapiens T-cell surface glycoprotein CD1a Proteins 0.000 claims description 2
- 101000738335 Homo sapiens T-cell surface glycoprotein CD3 zeta chain Proteins 0.000 claims description 2
- 101001115218 Homo sapiens Ubiquitin-40S ribosomal protein S27a Proteins 0.000 claims description 2
- 102000016878 Hypoxia-Inducible Factor 1 Human genes 0.000 claims description 2
- 108010028501 Hypoxia-Inducible Factor 1 Proteins 0.000 claims description 2
- 108091054729 IRF family Proteins 0.000 claims description 2
- 102000016854 Interferon Regulatory Factors Human genes 0.000 claims description 2
- 108010002352 Interleukin-1 Proteins 0.000 claims description 2
- 102000011845 Iodide peroxidase Human genes 0.000 claims description 2
- 108010036012 Iodide peroxidase Proteins 0.000 claims description 2
- 102000004856 Lectins Human genes 0.000 claims description 2
- 108090001090 Lectins Proteins 0.000 claims description 2
- 102000016267 Leptin Human genes 0.000 claims description 2
- 108010092277 Leptin Proteins 0.000 claims description 2
- 102000004058 Leukemia inhibitory factor Human genes 0.000 claims description 2
- 108090000581 Leukemia inhibitory factor Proteins 0.000 claims description 2
- 206010058467 Lung neoplasm malignant Diseases 0.000 claims description 2
- 102000047918 Myelin Basic Human genes 0.000 claims description 2
- 101710107068 Myelin basic protein Proteins 0.000 claims description 2
- 102000003896 Myeloperoxidases Human genes 0.000 claims description 2
- 108090000235 Myeloperoxidases Proteins 0.000 claims description 2
- 102100029156 Nucleolar protein of 40 kDa Human genes 0.000 claims description 2
- 101710159068 Nucleolar protein of 40 kDa Proteins 0.000 claims description 2
- 108090000630 Oncostatin M Proteins 0.000 claims description 2
- 102000004140 Oncostatin M Human genes 0.000 claims description 2
- 102100034219 Oxidation resistance protein 1 Human genes 0.000 claims description 2
- 102400000050 Oxytocin Human genes 0.000 claims description 2
- XNOPRXBHLZRZKH-UHFFFAOYSA-N Oxytocin Natural products N1C(=O)C(N)CSSCC(C(=O)N2C(CCC2)C(=O)NC(CC(C)C)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(CCC(N)=O)NC(=O)C(C(C)CC)NC(=O)C1CC1=CC=C(O)C=C1 XNOPRXBHLZRZKH-UHFFFAOYSA-N 0.000 claims description 2
- 101800000989 Oxytocin Proteins 0.000 claims description 2
- 102000015439 Phospholipases Human genes 0.000 claims description 2
- 108010064785 Phospholipases Proteins 0.000 claims description 2
- 102000045595 Phosphoprotein Phosphatases Human genes 0.000 claims description 2
- 108700019535 Phosphoprotein Phosphatases Proteins 0.000 claims description 2
- 102000012288 Phosphopyruvate Hydratase Human genes 0.000 claims description 2
- 108010022181 Phosphopyruvate Hydratase Proteins 0.000 claims description 2
- 102000001938 Plasminogen Activators Human genes 0.000 claims description 2
- 108010001014 Plasminogen Activators Proteins 0.000 claims description 2
- 206010060862 Prostate cancer Diseases 0.000 claims description 2
- 102000003923 Protein Kinase C Human genes 0.000 claims description 2
- 108090000315 Protein Kinase C Proteins 0.000 claims description 2
- 102000002727 Protein Tyrosine Phosphatase Human genes 0.000 claims description 2
- 102000057361 Pseudogenes Human genes 0.000 claims description 2
- 108091008109 Pseudogenes Proteins 0.000 claims description 2
- 102000017143 RNA Polymerase I Human genes 0.000 claims description 2
- 108010013845 RNA Polymerase I Proteins 0.000 claims description 2
- 102000044126 RNA-Binding Proteins Human genes 0.000 claims description 2
- 108700020471 RNA-Binding Proteins Proteins 0.000 claims description 2
- 102000006382 Ribonucleases Human genes 0.000 claims description 2
- 108010083644 Ribonucleases Proteins 0.000 claims description 2
- 101000677219 Schizosaccharomyces pombe (strain 972 / ATCC 24843) 60S ribosomal protein L33-A Proteins 0.000 claims description 2
- 101000691164 Schizosaccharomyces pombe (strain 972 / ATCC 24843) 60S ribosomal protein L43-A Proteins 0.000 claims description 2
- 101000732892 Schizosaccharomyces pombe (strain 972 / ATCC 24843) 60S ribosomal protein L8 Proteins 0.000 claims description 2
- 102100023921 Serine/threonine-protein kinase ATR Human genes 0.000 claims description 2
- 101710178061 Serine/threonine-protein kinase ATR Proteins 0.000 claims description 2
- 102000043912 Sestrin Human genes 0.000 claims description 2
- 208000000453 Skin Neoplasms Diseases 0.000 claims description 2
- 208000005718 Stomach Neoplasms Diseases 0.000 claims description 2
- 108091008874 T cell receptors Proteins 0.000 claims description 2
- 102000016266 T-Cell Antigen Receptors Human genes 0.000 claims description 2
- 102100024219 T-cell surface glycoprotein CD1a Human genes 0.000 claims description 2
- 102100037906 T-cell surface glycoprotein CD3 zeta chain Human genes 0.000 claims description 2
- 102000013090 Thioredoxin-Disulfide Reductase Human genes 0.000 claims description 2
- 108010079911 Thioredoxin-disulfide reductase Proteins 0.000 claims description 2
- 102000002689 Toll-like receptor Human genes 0.000 claims description 2
- 108020000411 Toll-like receptor Proteins 0.000 claims description 2
- 102100023341 Ubiquitin-40S ribosomal protein S27a Human genes 0.000 claims description 2
- 239000012190 activator Substances 0.000 claims description 2
- 210000001072 colon Anatomy 0.000 claims description 2
- 208000029742 colonic neoplasm Diseases 0.000 claims description 2
- ZUBDGKVDJUIMQQ-UBFCDGJISA-N endothelin-1 Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(O)=O)NC(=O)[C@H]1NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@@H](CC=2C=CC(O)=CC=2)NC(=O)[C@H](C(C)C)NC(=O)[C@H]2CSSC[C@@H](C(N[C@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N2)=O)NC(=O)[C@@H](CO)NC(=O)[C@H](N)CSSC1)C1=CNC=N1 ZUBDGKVDJUIMQQ-UBFCDGJISA-N 0.000 claims description 2
- 238000013467 fragmentation Methods 0.000 claims description 2
- 238000006062 fragmentation reaction Methods 0.000 claims description 2
- 206010017758 gastric cancer Diseases 0.000 claims description 2
- 102000006495 integrins Human genes 0.000 claims description 2
- 108010044426 integrins Proteins 0.000 claims description 2
- 201000002313 intestinal cancer Diseases 0.000 claims description 2
- 239000002523 lectin Substances 0.000 claims description 2
- 229940039781 leptin Drugs 0.000 claims description 2
- NRYBAZVQPHGZNS-ZSOCWYAHSA-N leptin Chemical compound O=C([C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CC(C)C)CCSC)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CS)C(O)=O NRYBAZVQPHGZNS-ZSOCWYAHSA-N 0.000 claims description 2
- 210000000265 leukocyte Anatomy 0.000 claims description 2
- 239000003446 ligand Substances 0.000 claims description 2
- 210000004072 lung Anatomy 0.000 claims description 2
- 201000005202 lung cancer Diseases 0.000 claims description 2
- 208000020816 lung neoplasm Diseases 0.000 claims description 2
- XNOPRXBHLZRZKH-DSZYJQQASA-N oxytocin Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@H](N)C(=O)N1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 XNOPRXBHLZRZKH-DSZYJQQASA-N 0.000 claims description 2
- 229960001723 oxytocin Drugs 0.000 claims description 2
- 229940127126 plasminogen activator Drugs 0.000 claims description 2
- 230000008488 polyadenylation Effects 0.000 claims description 2
- 210000002307 prostate Anatomy 0.000 claims description 2
- 108020000494 protein-tyrosine phosphatase Proteins 0.000 claims description 2
- 108010078070 scavenger receptors Proteins 0.000 claims description 2
- 102000014452 scavenger receptors Human genes 0.000 claims description 2
- 108700020508 sestrin Proteins 0.000 claims description 2
- 210000003491 skin Anatomy 0.000 claims description 2
- 201000000849 skin cancer Diseases 0.000 claims description 2
- 210000002784 stomach Anatomy 0.000 claims description 2
- 201000011549 stomach cancer Diseases 0.000 claims description 2
- 102100024113 40S ribosomal protein S15a Human genes 0.000 claims 1
- 102000006311 Cyclin D1 Human genes 0.000 claims 1
- 102100038885 Histone acetyltransferase p300 Human genes 0.000 claims 1
- 101001118566 Homo sapiens 40S ribosomal protein S15a Proteins 0.000 claims 1
- 102220588437 Keratin, type I cytoskeletal 18_S18A_mutation Human genes 0.000 claims 1
- 102000007999 Nuclear Proteins Human genes 0.000 claims 1
- 108010089610 Nuclear Proteins Proteins 0.000 claims 1
- 230000027455 binding Effects 0.000 description 51
- 238000004458 analytical method Methods 0.000 description 31
- 239000000047 product Substances 0.000 description 24
- 210000004369 blood Anatomy 0.000 description 20
- 239000008280 blood Substances 0.000 description 20
- 239000011159 matrix material Substances 0.000 description 18
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 17
- 238000002790 cross-validation Methods 0.000 description 17
- 150000007523 nucleic acids Chemical class 0.000 description 16
- 238000010238 partial least squares regression Methods 0.000 description 16
- 238000004519 manufacturing process Methods 0.000 description 15
- 102000039446 nucleic acids Human genes 0.000 description 15
- 108020004707 nucleic acids Proteins 0.000 description 15
- 239000003550 marker Substances 0.000 description 14
- 238000013459 approach Methods 0.000 description 13
- 238000009396 hybridization Methods 0.000 description 13
- 239000012528 membrane Substances 0.000 description 13
- 230000003321 amplification Effects 0.000 description 12
- 238000003199 nucleic acid amplification method Methods 0.000 description 12
- 238000003786 synthesis reaction Methods 0.000 description 11
- 108020004635 Complementary DNA Proteins 0.000 description 10
- 230000015572 biosynthetic process Effects 0.000 description 10
- 238000002493 microarray Methods 0.000 description 9
- 108091000080 Phosphotransferase Proteins 0.000 description 8
- 102000020233 phosphotransferase Human genes 0.000 description 8
- 239000013598 vector Substances 0.000 description 8
- 102100032420 Protein S100-A9 Human genes 0.000 description 7
- 238000013145 classification model Methods 0.000 description 7
- 238000001514 detection method Methods 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 7
- 239000012634 fragment Substances 0.000 description 7
- 238000010200 validation analysis Methods 0.000 description 7
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- 238000002372 labelling Methods 0.000 description 6
- 230000011664 signaling Effects 0.000 description 6
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 5
- 238000011161 development Methods 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 229940088598 enzyme Drugs 0.000 description 5
- 238000011068 loading method Methods 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 238000003752 polymerase chain reaction Methods 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 241000894007 species Species 0.000 description 5
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
- 108010052495 Calgranulin B Proteins 0.000 description 4
- 238000000018 DNA microarray Methods 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- 108091093037 Peptide nucleic acid Proteins 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 239000012472 biological sample Substances 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 238000010195 expression analysis Methods 0.000 description 4
- 239000012530 fluid Substances 0.000 description 4
- 230000004048 modification Effects 0.000 description 4
- 238000012986 modification Methods 0.000 description 4
- 238000010606 normalization Methods 0.000 description 4
- 229910052760 oxygen Inorganic materials 0.000 description 4
- 239000003642 reactive oxygen metabolite Substances 0.000 description 4
- 238000010839 reverse transcription Methods 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- 101150029115 HOPX gene Proteins 0.000 description 3
- 239000004677 Nylon Substances 0.000 description 3
- 101710156990 Protein S100-A9 Proteins 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 230000002159 abnormal effect Effects 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 150000007513 acids Chemical class 0.000 description 3
- 238000003491 array Methods 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 230000008827 biological function Effects 0.000 description 3
- 238000001574 biopsy Methods 0.000 description 3
- 210000004556 brain Anatomy 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 239000007850 fluorescent dye Substances 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 238000003384 imaging method Methods 0.000 description 3
- 230000003100 immobilizing effect Effects 0.000 description 3
- 230000001965 increasing effect Effects 0.000 description 3
- 230000003993 interaction Effects 0.000 description 3
- 208000024312 invasive carcinoma Diseases 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000002773 nucleotide Substances 0.000 description 3
- 125000003729 nucleotide group Chemical group 0.000 description 3
- 229920001778 nylon Polymers 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 238000004416 surface enhanced Raman spectroscopy Methods 0.000 description 3
- 238000012549 training Methods 0.000 description 3
- ABEXEQSGABRUHS-UHFFFAOYSA-N 16-methylheptadecyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC(C)C ABEXEQSGABRUHS-UHFFFAOYSA-N 0.000 description 2
- 208000024827 Alzheimer disease Diseases 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 2
- 102100030801 Elongation factor 1-alpha 1 Human genes 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 102100020760 Ferritin heavy chain Human genes 0.000 description 2
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
- 101000920078 Homo sapiens Elongation factor 1-alpha 1 Proteins 0.000 description 2
- 101001002987 Homo sapiens Ferritin heavy chain Proteins 0.000 description 2
- 208000037396 Intraductal Noninfiltrating Carcinoma Diseases 0.000 description 2
- 241000764238 Isis Species 0.000 description 2
- 241000042032 Petrocephalus catostoma Species 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- 239000004793 Polystyrene Substances 0.000 description 2
- 238000012952 Resampling Methods 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 101710119418 Superoxide dismutase [Mn] Proteins 0.000 description 2
- 102100032891 Superoxide dismutase [Mn], mitochondrial Human genes 0.000 description 2
- 101710202572 Superoxide dismutase [Mn], mitochondrial Proteins 0.000 description 2
- 102100040103 Upstream stimulatory factor 2 Human genes 0.000 description 2
- 230000005856 abnormality Effects 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 239000008186 active pharmaceutical agent Substances 0.000 description 2
- 238000000540 analysis of variance Methods 0.000 description 2
- 238000010420 art technique Methods 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 238000003705 background correction Methods 0.000 description 2
- 239000011324 bead Substances 0.000 description 2
- 229960002685 biotin Drugs 0.000 description 2
- 235000020958 biotin Nutrition 0.000 description 2
- 239000011616 biotin Substances 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 210000000349 chromosome Anatomy 0.000 description 2
- 238000007621 cluster analysis Methods 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 description 2
- SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 description 2
- 238000007405 data analysis Methods 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 238000009795 derivation Methods 0.000 description 2
- 238000012631 diagnostic technique Methods 0.000 description 2
- 208000028715 ductal breast carcinoma in situ Diseases 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- 235000013601 eggs Nutrition 0.000 description 2
- 201000003373 familial cold autoinflammatory syndrome 3 Diseases 0.000 description 2
- 125000000524 functional group Chemical group 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 230000003394 haemopoietic effect Effects 0.000 description 2
- 238000005417 image-selected in vivo spectroscopy Methods 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 238000012739 integrated shape imaging system Methods 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 230000003211 malignant effect Effects 0.000 description 2
- 230000001404 mediated effect Effects 0.000 description 2
- 238000000491 multivariate analysis Methods 0.000 description 2
- 230000036961 partial effect Effects 0.000 description 2
- 230000000704 physical effect Effects 0.000 description 2
- 229920002223 polystyrene Polymers 0.000 description 2
- 238000007639 printing Methods 0.000 description 2
- 238000011002 quantification Methods 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 238000000611 regression analysis Methods 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 230000009870 specific binding Effects 0.000 description 2
- 238000007619 statistical method Methods 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- 230000009897 systematic effect Effects 0.000 description 2
- 230000009885 systemic effect Effects 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- ZRZROXNBKJAOKB-GFVHOAGBSA-N (2s)-2-[[2-[[(2s)-2-[[(2s)-2-[[(2s)-2-[[2-[[2-[[(2s)-2-[[(2s)-2-amino-3-(1h-indol-3-yl)propanoyl]amino]propanoyl]amino]acetyl]amino]acetyl]amino]-3-carboxypropanoyl]amino]propanoyl]amino]-3-hydroxypropanoyl]amino]acetyl]amino]pentanedioic acid Chemical compound C1=CC=C2C(C[C@H](N)C(=O)N[C@@H](C)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(O)=O)=CNC2=C1 ZRZROXNBKJAOKB-GFVHOAGBSA-N 0.000 description 1
- KVUYSIIZYQUVMT-UHFFFAOYSA-N 1,2-diisothiocyanatoethane Chemical compound S=C=NCCN=C=S KVUYSIIZYQUVMT-UHFFFAOYSA-N 0.000 description 1
- PFFIDZXUXFLSSR-UHFFFAOYSA-N 1-methyl-N-[2-(4-methylpentan-2-yl)-3-thienyl]-3-(trifluoromethyl)pyrazole-4-carboxamide Chemical compound S1C=CC(NC(=O)C=2C(=NN(C)C=2)C(F)(F)F)=C1C(C)CC(C)C PFFIDZXUXFLSSR-UHFFFAOYSA-N 0.000 description 1
- BPPVUXSMLBXYGG-UHFFFAOYSA-N 4-[3-(4,5-dihydro-1,2-oxazol-3-yl)-2-methyl-4-methylsulfonylbenzoyl]-2-methyl-1h-pyrazol-3-one Chemical compound CC1=C(C(=O)C=2C(N(C)NC=2)=O)C=CC(S(C)(=O)=O)=C1C1=NOCC1 BPPVUXSMLBXYGG-UHFFFAOYSA-N 0.000 description 1
- 102100023415 40S ribosomal protein S20 Human genes 0.000 description 1
- 102100027271 40S ribosomal protein SA Human genes 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- BSFODEXXVBBYOC-UHFFFAOYSA-N 8-[4-(dimethylamino)butan-2-ylamino]quinolin-6-ol Chemical compound C1=CN=C2C(NC(CCN(C)C)C)=CC(O)=CC2=C1 BSFODEXXVBBYOC-UHFFFAOYSA-N 0.000 description 1
- 241001556567 Acanthamoeba polyphaga mimivirus Species 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- 241000219498 Alnus glutinosa Species 0.000 description 1
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 1
- 102100036013 Antigen-presenting glycoprotein CD1d Human genes 0.000 description 1
- 102100028449 Arginine-glutamic acid dipeptide repeats protein Human genes 0.000 description 1
- 241000271566 Aves Species 0.000 description 1
- 108090001008 Avidin Proteins 0.000 description 1
- 241000534000 Berula erecta Species 0.000 description 1
- 208000003174 Brain Neoplasms Diseases 0.000 description 1
- 101100501250 Caenorhabditis elegans elo-3 gene Proteins 0.000 description 1
- 101100074328 Caenorhabditis elegans lec-7 gene Proteins 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 241000700198 Cavia Species 0.000 description 1
- 241001091551 Clio Species 0.000 description 1
- 239000004971 Cross linker Substances 0.000 description 1
- 102000001493 Cyclophilins Human genes 0.000 description 1
- 108010068682 Cyclophilins Proteins 0.000 description 1
- 102000000634 Cytochrome c oxidase subunit IV Human genes 0.000 description 1
- 108090000365 Cytochrome-c oxidases Proteins 0.000 description 1
- 102000052510 DNA-Binding Proteins Human genes 0.000 description 1
- 101710096438 DNA-binding protein Proteins 0.000 description 1
- 101150105088 Dele1 gene Proteins 0.000 description 1
- 108010051088 Delta Sleep-Inducing Peptide Proteins 0.000 description 1
- 102000007260 Deoxyribonuclease I Human genes 0.000 description 1
- 108010008532 Deoxyribonuclease I Proteins 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 101100278839 Drosophila melanogaster sw gene Proteins 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- 241001658031 Eris Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241000238558 Eucarida Species 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 241000628997 Flos Species 0.000 description 1
- 102100024165 G1/S-specific cyclin-D1 Human genes 0.000 description 1
- 102100036263 Glutamyl-tRNA(Gln) amidotransferase subunit C, mitochondrial Human genes 0.000 description 1
- 102100031181 Glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 1
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 1
- 102000000039 Heat Shock Transcription Factor Human genes 0.000 description 1
- 108050008339 Heat Shock Transcription Factor Proteins 0.000 description 1
- 244000043261 Hevea brasiliensis Species 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 102100028798 Homeodomain-only protein Human genes 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 101001114932 Homo sapiens 40S ribosomal protein S20 Proteins 0.000 description 1
- 101000694288 Homo sapiens 40S ribosomal protein SA Proteins 0.000 description 1
- 101000716121 Homo sapiens Antigen-presenting glycoprotein CD1d Proteins 0.000 description 1
- 101001061654 Homo sapiens Arginine-glutamic acid dipeptide repeats protein Proteins 0.000 description 1
- 101001001786 Homo sapiens Glutamyl-tRNA(Gln) amidotransferase subunit C, mitochondrial Proteins 0.000 description 1
- 101001041393 Homo sapiens Serine protease HTRA1 Proteins 0.000 description 1
- 101000633680 Homo sapiens Tetratricopeptide repeat protein 37 Proteins 0.000 description 1
- 101001010792 Homo sapiens Transcriptional regulator ERG Proteins 0.000 description 1
- 101000671649 Homo sapiens Upstream stimulatory factor 2 Proteins 0.000 description 1
- 241000257303 Hymenoptera Species 0.000 description 1
- 206010065042 Immune reconstitution inflammatory syndrome Diseases 0.000 description 1
- 102000008394 Immunoglobulin Fragments Human genes 0.000 description 1
- 108010021625 Immunoglobulin Fragments Proteins 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102100034343 Integrase Human genes 0.000 description 1
- 206010073094 Intraductal proliferative breast lesion Diseases 0.000 description 1
- 102100038609 Lactoperoxidase Human genes 0.000 description 1
- 108010023244 Lactoperoxidase Proteins 0.000 description 1
- 244000211187 Lepidium sativum Species 0.000 description 1
- 235000007849 Lepidium sativum Nutrition 0.000 description 1
- 241000337544 Limnoriidae Species 0.000 description 1
- 229920001410 Microfiber Polymers 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 241000428199 Mustelinae Species 0.000 description 1
- 101100108611 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) alg-8 gene Proteins 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 108010068113 Octamer Transcription Factor-6 Proteins 0.000 description 1
- 241001024099 Olla Species 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 102100026458 POU domain, class 3, transcription factor 1 Human genes 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- 241001674048 Phthiraptera Species 0.000 description 1
- 241000288906 Primates Species 0.000 description 1
- 102100032421 Protein S100-A6 Human genes 0.000 description 1
- 240000004350 Prunus spinosa Species 0.000 description 1
- 235000010829 Prunus spinosa Nutrition 0.000 description 1
- 101150107341 RERE gene Proteins 0.000 description 1
- 238000002123 RNA extraction Methods 0.000 description 1
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 102000009661 Repressor Proteins Human genes 0.000 description 1
- 108010034634 Repressor Proteins Proteins 0.000 description 1
- 102000009738 Ribosomal Protein S6 Kinases Human genes 0.000 description 1
- 108010034782 Ribosomal Protein S6 Kinases Proteins 0.000 description 1
- 108010005260 S100 Calcium Binding Protein A6 Proteins 0.000 description 1
- 102100037658 STING ER exit protein Human genes 0.000 description 1
- 101710198240 STING ER exit protein Proteins 0.000 description 1
- 101000679735 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) 60S ribosomal protein L16-A Proteins 0.000 description 1
- 102100037205 Sal-like protein 2 Human genes 0.000 description 1
- 101710192308 Sal-like protein 2 Proteins 0.000 description 1
- 235000017276 Salvia Nutrition 0.000 description 1
- 241001072909 Salvia Species 0.000 description 1
- 102100021119 Serine protease HTRA1 Human genes 0.000 description 1
- 102220580081 Serrate RNA effector molecule homolog_S18D_mutation Human genes 0.000 description 1
- 241000033695 Sige Species 0.000 description 1
- 102000011990 Sirtuin Human genes 0.000 description 1
- 108050002485 Sirtuin Proteins 0.000 description 1
- 102100030584 Small integral membrane protein 1 Human genes 0.000 description 1
- 108010090804 Streptavidin Proteins 0.000 description 1
- 238000000692 Student's t-test Methods 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 206010051379 Systemic Inflammatory Response Syndrome Diseases 0.000 description 1
- 239000004809 Teflon Substances 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- 102100030784 Telomeric repeat-binding factor 2 Human genes 0.000 description 1
- 108050002561 Telomeric repeat-binding factor 2 Proteins 0.000 description 1
- 241000897276 Termes Species 0.000 description 1
- 102100029210 Tetratricopeptide repeat protein 37 Human genes 0.000 description 1
- 241000863032 Trieres Species 0.000 description 1
- 241001504505 Troglodytes troglodytes Species 0.000 description 1
- 102100033649 Tumor necrosis factor alpha-induced protein 8 Human genes 0.000 description 1
- 101710098767 Tumor necrosis factor alpha-induced protein 8 Proteins 0.000 description 1
- 101710184190 Upstream stimulatory factor 2 Proteins 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 239000001132 aluminium potassium sulphate Substances 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 239000002870 angiogenesis inducing agent Substances 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 235000013405 beer Nutrition 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 230000008499 blood brain barrier function Effects 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 210000001218 blood-brain barrier Anatomy 0.000 description 1
- 210000004958 brain cell Anatomy 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000004281 calcium formate Substances 0.000 description 1
- 239000000378 calcium silicate Substances 0.000 description 1
- 238000004422 calculation algorithm Methods 0.000 description 1
- 235000009120 camo Nutrition 0.000 description 1
- 244000213578 camo Species 0.000 description 1
- FPPNZSSZRUTDAP-UWFZAAFLSA-N carbenicillin Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)C(C(O)=O)C1=CC=CC=C1 FPPNZSSZRUTDAP-UWFZAAFLSA-N 0.000 description 1
- 229960003669 carbenicillin Drugs 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 239000013068 control sample Substances 0.000 description 1
- 239000013256 coordination polymer Substances 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 230000001351 cycling effect Effects 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 description 1
- HAAZLUGHYHWQIW-KVQBGUIXSA-N dGTP Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HAAZLUGHYHWQIW-KVQBGUIXSA-N 0.000 description 1
- NHVNXKFIZYSCEB-XLPZGREQSA-N dTTP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 NHVNXKFIZYSCEB-XLPZGREQSA-N 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 239000012502 diagnostic product Substances 0.000 description 1
- 238000012850 discrimination method Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 201000007273 ductal carcinoma in situ Diseases 0.000 description 1
- 230000008846 dynamic interplay Effects 0.000 description 1
- 210000005069 ears Anatomy 0.000 description 1
- 238000002571 electroretinography Methods 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000013401 experimental design Methods 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 239000004225 ferrous lactate Substances 0.000 description 1
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
- 230000005714 functional activity Effects 0.000 description 1
- 235000021474 generally recognized As safe (food) Nutrition 0.000 description 1
- 235000021473 generally recognized as safe (food ingredients) Nutrition 0.000 description 1
- 108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000008240 homogeneous mixture Substances 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 238000010191 image analysis Methods 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 201000004933 in situ carcinoma Diseases 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000028709 inflammatory response Effects 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 206010073095 invasive ductal breast carcinoma Diseases 0.000 description 1
- 201000010985 invasive ductal carcinoma Diseases 0.000 description 1
- 206010073096 invasive lobular breast carcinoma Diseases 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 229940057428 lactoperoxidase Drugs 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 238000009607 mammography Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000004066 metabolic change Effects 0.000 description 1
- 230000011987 methylation Effects 0.000 description 1
- 238000007069 methylation reaction Methods 0.000 description 1
- 229910052618 mica group Inorganic materials 0.000 description 1
- 238000010208 microarray analysis Methods 0.000 description 1
- 239000003658 microfiber Substances 0.000 description 1
- 230000002438 mitochondrial effect Effects 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 238000005312 nonlinear dynamic Methods 0.000 description 1
- 238000001543 one-way ANOVA Methods 0.000 description 1
- 238000007410 oral glucose tolerance test Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 238000000163 radioactive labelling Methods 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 238000003757 reverse transcription PCR Methods 0.000 description 1
- PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 230000019491 signal transduction Effects 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 239000011343 solid material Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 229910021653 sulphate ion Inorganic materials 0.000 description 1
- 238000012706 support-vector machine Methods 0.000 description 1
- 238000011477 surgical intervention Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 229920005613 synthetic organic polymer Polymers 0.000 description 1
- 238000012353 t test Methods 0.000 description 1
- 210000003411 telomere Anatomy 0.000 description 1
- 102000055501 telomere Human genes 0.000 description 1
- 108091035539 telomere Proteins 0.000 description 1
- 125000002088 tosyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1C([H])([H])[H])S(*)(=O)=O 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 208000007004 trichohepatoenteric syndrome Diseases 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 238000012285 ultrasound imaging Methods 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Hospice & Palliative Care (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0412301.4A GB0412301D0 (en) | 2004-06-02 | 2004-06-02 | Product and method |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200610644B true ZA200610644B (en) | 2008-07-30 |
Family
ID=32696533
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200610644A ZA200610644B (en) | 2004-06-02 | 2005-06-02 | Oligonucleotides for cancer diagnosis |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US8105773B2 (ja) |
| EP (1) | EP1766056B1 (ja) |
| JP (1) | JP5060945B2 (ja) |
| CN (1) | CN101027410A (ja) |
| AP (1) | AP2006003862A0 (ja) |
| AT (1) | ATE493511T1 (ja) |
| AU (1) | AU2005250219B2 (ja) |
| CA (1) | CA2568889A1 (ja) |
| DE (1) | DE602005025633D1 (ja) |
| DK (1) | DK1766056T3 (ja) |
| ES (1) | ES2358910T3 (ja) |
| GB (1) | GB0412301D0 (ja) |
| NO (1) | NO20065939L (ja) |
| NZ (1) | NZ551797A (ja) |
| SI (1) | SI1766056T1 (ja) |
| WO (1) | WO2005118851A1 (ja) |
| ZA (1) | ZA200610644B (ja) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006128082A2 (en) * | 2005-05-26 | 2006-11-30 | The Johns Hopkins University | Biomarkers for breast cancer |
| JP2007275027A (ja) * | 2006-04-12 | 2007-10-25 | Fujifilm Corp | 癌関連欠失遺伝子マーカーを用いた癌の診断方法 |
| JP5208477B2 (ja) * | 2007-10-12 | 2013-06-12 | 生化学工業株式会社 | 遺伝子サブトラクション用の担体及びその利用 |
| WO2011063232A1 (en) * | 2009-11-20 | 2011-05-26 | University Of Louisville Research Foundation, Inc. | Biomarkers of cancer |
| GB201000688D0 (en) * | 2010-01-15 | 2010-03-03 | Diagenic Asa | Product and method |
| CN110444287B (zh) * | 2011-04-29 | 2024-02-06 | 癌症预防和治疗有限公司 | 使用分类系统及其试剂盒识别和诊断肺部疾病的方法 |
| KR20140099874A (ko) * | 2011-11-02 | 2014-08-13 | 나노프리시젼 프로덕츠 인코포레이션 | 캐스텔레이티드 광섬유 케이블 유지 구조 |
| JP6486826B2 (ja) | 2012-10-01 | 2019-03-20 | ミレニアム ファーマシューティカルズ， インコーポレイテッドＭｉｌｌｅｎｎｉｕｍ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． | 阻害剤に対する応答を予測するためのバイオマーカーおよび方法、ならびにそれらの使用 |
| EP2922971B1 (en) * | 2012-11-20 | 2018-10-17 | Lund, Tore Eiliv | Gene expression profile in diagnostics |
| JP6498210B2 (ja) | 2013-12-29 | 2019-04-10 | チュアラボ オンコロジー, インコーポレーテッドCurelab Oncology, Inc. | 炎症関連疾患の治療と予防のためのｐ６２／ｓｑｓｔｍ１に関する方法と組成物 |
| KR102523245B1 (ko) * | 2014-06-18 | 2023-04-20 | 도레이 카부시키가이샤 | 식도암의 검출 키트 또는 디바이스 및 검출 방법 |
| FR3029210A1 (fr) | 2014-11-27 | 2016-06-03 | Centre Nat De La Rech Scient (Cnrs) | Methode de pronostic d'hemopathies |
| US10140708B2 (en) * | 2016-01-21 | 2018-11-27 | Riverside Research Institute | Method for gestational age estimation and embryonic mutant detection |
| GB201611738D0 (en) * | 2016-07-05 | 2016-08-17 | Cambridge Entpr Ltd | Biomarkers for inflammatory bowel disease |
| WO2019036388A1 (en) * | 2017-08-14 | 2019-02-21 | Raytheon Company | ALGORITHM OF SUBTRACTION FOR DETECTION OF TUMORS |
| CN109529018B (zh) * | 2019-01-10 | 2021-11-30 | 南方医科大学南方医院 | Atxn2l用于制备逆转胃癌奥沙利铂耐药的药物的用途 |
| CN109596611A (zh) * | 2019-01-21 | 2019-04-09 | 湖北紫荆生物技术有限公司 | 一种水体钙含量测试剂及水体钙含量测量方法 |
| US11475558B2 (en) | 2019-11-13 | 2022-10-18 | Raytheon Company | Organ isolation in scan data |
| US11282209B2 (en) | 2020-01-10 | 2022-03-22 | Raytheon Company | System and method for generating contours |
| US11562512B2 (en) | 2020-12-09 | 2023-01-24 | Raytheon Company | System and method for generating and displaying contours |
| US11893745B2 (en) | 2020-12-09 | 2024-02-06 | Raytheon Company | System and method for generating and displaying contours |
| CN113913436B (zh) * | 2021-11-18 | 2023-09-29 | 天津市肿瘤医院（天津医科大学肿瘤医院） | 逆转录转座基因l1-atp8b1及其作为肺鳞癌标志物的用途和治疗肺鳞癌的药物 |
| CN115976212B (zh) * | 2022-12-21 | 2024-06-11 | 四川大学华西医院 | 一种用于检测骨肿瘤诊断相关基因的探针库及试剂盒 |
Family Cites Families (77)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4981783A (en) | 1986-04-16 | 1991-01-01 | Montefiore Medical Center | Method for detecting pathological conditions |
| US6040138A (en) | 1995-09-15 | 2000-03-21 | Affymetrix, Inc. | Expression monitoring by hybridization to high density oligonucleotide arrays |
| US5871928A (en) | 1989-06-07 | 1999-02-16 | Fodor; Stephen P. A. | Methods for nucleic acid analysis |
| US5800992A (en) | 1989-06-07 | 1998-09-01 | Fodor; Stephen P.A. | Method of detecting nucleic acids |
| US5925525A (en) | 1989-06-07 | 1999-07-20 | Affymetrix, Inc. | Method of identifying nucleotide differences |
| JP2802125B2 (ja) | 1989-06-23 | 1998-09-24 | キヤノン株式会社 | 核酸の検出方法 |
| US5474796A (en) | 1991-09-04 | 1995-12-12 | Protogene Laboratories, Inc. | Method and apparatus for conducting an array of chemical reactions on a support surface |
| DE69214243T2 (de) | 1991-09-23 | 1997-02-06 | Pfizer | Verfahren für die Detektion von spezifische mRNS und DNS in Zellen |
| GB2260811B (en) | 1991-10-23 | 1995-07-05 | Yorkshire Cancer Research Camp | Detection of malignant tumours |
| AU691469B2 (en) | 1992-03-04 | 1998-05-21 | Synaptic Pharmaceutical Corporation | DNA encoding taurine and gaba transporters and uses thereof |
| US6114114A (en) | 1992-07-17 | 2000-09-05 | Incyte Pharmaceuticals, Inc. | Comparative gene transcript analysis |
| US5633137A (en) | 1992-12-01 | 1997-05-27 | The University Of South Florida | Method for measuring specific gene expression: transcriptional activity per gene dose |
| US5677125A (en) | 1994-01-14 | 1997-10-14 | Vanderbilt University | Method of detection and diagnosis of pre-invasive cancer |
| US5830645A (en) | 1994-12-09 | 1998-11-03 | The Regents Of The University Of California | Comparative fluorescence hybridization to nucleic acid arrays |
| US5545531A (en) | 1995-06-07 | 1996-08-13 | Affymax Technologies N.V. | Methods for making a device for concurrently processing multiple biological chip assays |
| US6156502A (en) | 1995-12-21 | 2000-12-05 | Beattie; Kenneth Loren | Arbitrary sequence oligonucleotide fingerprinting |
| AU2253397A (en) | 1996-01-23 | 1997-08-20 | Affymetrix, Inc. | Nucleic acid analysis techniques |
| WO1997029212A1 (en) | 1996-02-08 | 1997-08-14 | Affymetrix, Inc. | Chip-based speciation and phenotypic characterization of microorganisms |
| WO1998008083A1 (en) | 1996-08-20 | 1998-02-26 | Motorola Inc. | Method and apparatus for detecting predetermined molecular structures in a sample |
| US6235474B1 (en) | 1996-12-30 | 2001-05-22 | The Johns Hopkins University | Methods and kits for diagnosing and determination of the predisposition for diseases |
| US6190857B1 (en) | 1997-03-24 | 2001-02-20 | Urocor, Inc. | Diagnosis of disease state using MRNA profiles in peripheral leukocytes |
| NO972006D0 (no) * | 1997-04-30 | 1997-04-30 | Forskningsparken I Aas As | Ny metode for diagnose av sykdommer |
| US5994076A (en) | 1997-05-21 | 1999-11-30 | Clontech Laboratories, Inc. | Methods of assaying differential expression |
| WO1999006831A2 (en) | 1997-07-29 | 1999-02-11 | Dorssers Lambert C J | Breast cancer resistance genes, methods for their detection and uses thereof |
| US6607879B1 (en) | 1998-02-09 | 2003-08-19 | Incyte Corporation | Compositions for the detection of blood cell and immunological response gene expression |
| US6174680B1 (en) * | 1998-12-30 | 2001-01-16 | Dana-Farber Cancer Institute, Inc. | Method for identifying mismatch repair glycosylase reactive sites, compounds and uses thereof |
| CA2318789C (en) | 1998-02-25 | 2011-05-10 | The United States Of America As Represented By The Secretary Department Of Health And Human Services | Cellular arrays for rapid molecular profiling |
| US6004755A (en) | 1998-04-07 | 1999-12-21 | Incyte Pharmaceuticals, Inc. | Quantitative microarray hybridizaton assays |
| CN1313908A (zh) | 1998-08-21 | 2001-09-19 | 纳克斯科尔公司 | 使用可交联的固定的核酸的检测法 |
| US20090233276A1 (en) * | 1998-09-22 | 2009-09-17 | Oncomedx, Inc. | Method Enabling the Use of Extracellular Ribonucleic Acid (RNA) Extracted from Plasma or Serum to Detect, Monitor or Evaluate Cancer or Premalignant Conditions |
| US6593084B2 (en) | 1998-10-13 | 2003-07-15 | Robert E. Bird | Carcinogen assay |
| WO2000022172A1 (en) | 1998-10-13 | 2000-04-20 | Clontech Laboratories, Inc. | Nucleic acid arrays |
| JP5213202B2 (ja) | 1998-10-28 | 2013-06-19 | バイシス・インコーポレーテツド | 細胞アレイならびに遺伝障害マーカーの検出および使用方法 |
| WO2000026412A1 (en) | 1998-11-02 | 2000-05-11 | Kenneth Loren Beattie | Nucleic acid analysis using sequence-targeted tandem hybridization |
| US20040241726A1 (en) | 1999-01-06 | 2004-12-02 | Chondrogene Limited | Method for the detection of allergies related gene transcripts in blood |
| US20050042630A1 (en) | 1999-01-06 | 2005-02-24 | Chondrogene Limited | Method for the detection of asthma related gene transcripts in blood |
| US20040248169A1 (en) | 1999-01-06 | 2004-12-09 | Chondrogene Limited | Method for the detection of obesity related gene transcripts in blood |
| US20040265868A1 (en) | 1999-01-06 | 2004-12-30 | Chondrogene Limited | Method for the detection of depression related gene transcripts in blood |
| US20050123938A1 (en) | 1999-01-06 | 2005-06-09 | Chondrogene Limited | Method for the detection of osteoarthritis related gene transcripts in blood |
| WO2000040749A2 (en) | 1999-01-06 | 2000-07-13 | Genenews Inc. | Method for the detection of gene transcripts in blood and uses thereof |
| US20040241728A1 (en) | 1999-01-06 | 2004-12-02 | Chondrogene Limited | Method for the detection of lung disease related gene transcripts in blood |
| US20040265869A1 (en) | 1999-01-06 | 2004-12-30 | Chondrogene Limited | Method for the detection of type II diabetes related gene transcripts in blood |
| US20050003394A1 (en) | 1999-01-06 | 2005-01-06 | Chondrogene Limited | Method for the detection of rheumatoid arthritis related gene transcripts in blood |
| US20040248170A1 (en) | 1999-01-06 | 2004-12-09 | Chondrogene Limited | Method for the detection of hyperlipidemia related gene transcripts in blood |
| US7473528B2 (en) | 1999-01-06 | 2009-01-06 | Genenews Inc. | Method for the detection of Chagas disease related gene transcripts in blood |
| US20040241727A1 (en) | 1999-01-06 | 2004-12-02 | Chondrogene Limited | Method for the detection of schizophrenia related gene transcripts in blood |
| DE19937187A1 (de) * | 1999-08-06 | 2001-03-01 | Qiagen Gmbh | Automatisierte Proteinreinigung im Multiwellformat durch Vakuumfiltration |
| AU2001278076A1 (en) * | 2000-07-26 | 2002-02-05 | Applied Genomics, Inc. | Bstp-5 proteins and related reagents and methods of use thereof |
| US7108969B1 (en) * | 2000-09-08 | 2006-09-19 | Affymetrix, Inc. | Methods for detecting and diagnosing oral cancer |
| US6955876B2 (en) * | 2000-11-01 | 2005-10-18 | Kane Michael D | Compositions and systems for identifying and comparing expressed genes (mRNAs) in eukaryotic organisms |
| WO2002059367A2 (en) | 2000-11-30 | 2002-08-01 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Diagnostic microarray for inflammatory bowel disease, crohn's disease and ulcerative colitis |
| EP1350114A2 (en) * | 2001-01-12 | 2003-10-08 | Yale University | Detection of survivin in the biological fluids of cancer patients |
| US20020132274A1 (en) * | 2001-01-17 | 2002-09-19 | Nevalainen Marja T. | Diagnostic and monitorings methods for cancer |
| AU2002253878A1 (en) | 2001-01-25 | 2002-08-06 | Gene Logic, Inc. | Gene expression profiles in breast tissue |
| AU2002237124B2 (en) | 2001-02-28 | 2008-03-06 | Chondrogene Inc. | Compositions and methods relating to osteoarthritis |
| WO2002088750A2 (en) * | 2001-05-02 | 2002-11-07 | Oxford Glycosciences (Uk) Ltd | Proteins, genes and their use for diagnosis and treatment of breast cancer |
| US20020169560A1 (en) | 2001-05-12 | 2002-11-14 | X-Mine | Analysis mechanism for genetic data |
| US7335467B2 (en) * | 2001-05-15 | 2008-02-26 | Ludwig Institute For Cancer Research | Breast cancer antigens |
| US20030036077A1 (en) * | 2001-05-31 | 2003-02-20 | Chronix Biomedical | Methods for generating an mRNA expression profile from an ecellular mRNA containing blood sample and using the same to identify functional state markers |
| WO2003001985A2 (en) * | 2001-06-28 | 2003-01-09 | Dermtech International | Method for detection of melanoma |
| WO2003008963A1 (en) * | 2001-07-18 | 2003-01-30 | University Of Louisville Research Foundation, Inc. | E-genechip online web service for data mining bioinformatics |
| US7229774B2 (en) * | 2001-08-02 | 2007-06-12 | Regents Of The University Of Michigan | Expression profile of prostate cancer |
| US7622260B2 (en) * | 2001-09-05 | 2009-11-24 | The Brigham And Women's Hospital, Inc. | Diagnostic and prognostic tests |
| US7371736B2 (en) * | 2001-11-07 | 2008-05-13 | The Board Of Trustees Of The University Of Arkansas | Gene expression profiling based identification of DKK1 as a potential therapeutic targets for controlling bone loss |
| US7668659B2 (en) * | 2001-11-07 | 2010-02-23 | The Board Of Trustees Of The University Of Arkansas | Diagnosis and classification of multiple myeloma |
| US20030232350A1 (en) * | 2001-11-13 | 2003-12-18 | Eos Biotechnology, Inc. | Methods of diagnosis of cancer, compositions and methods of screening for modulators of cancer |
| WO2003041562A2 (en) * | 2001-11-14 | 2003-05-22 | Whitehead Institute For Biomedical Research | Molecular cancer diagnosis using tumor gene expression signature |
| AU2002361908A1 (en) * | 2001-12-31 | 2003-07-24 | Quark Biotech, Inc. | Methods for identifying marker genes for cancer |
| US20030195431A1 (en) * | 2002-04-10 | 2003-10-16 | Sukhatme Vikas P. | Observation of effects of body fluids on indicator cells for disease diagnosis |
| WO2003100000A2 (en) * | 2002-05-24 | 2003-12-04 | Tularik Inc. | Amplification and overexpression of oncogenes |
| CN100478689C (zh) * | 2002-08-30 | 2009-04-15 | 肿瘤疗法科学股份有限公司 | 多肽及其用途 |
| EP1581652A4 (en) | 2002-09-12 | 2008-02-13 | Genenews Corp | IDENTIFICATION OF SEQUENCES PARTICULAR USEFUL IN THE DIAGNOSIS AND IDENTIFICATION OF THERAPEUTIC TARGETS FOR OSTEO ARTHRITIS |
| US20060024692A1 (en) * | 2002-09-30 | 2006-02-02 | Oncotherapy Science, Inc. | Method for diagnosing non-small cell lung cancers |
| GB0227238D0 (en) * | 2002-11-21 | 2002-12-31 | Diagenic As | Product and method |
| US7910550B2 (en) * | 2004-04-16 | 2011-03-22 | Stc.Unm | Human kunitz-type inhibitor with enhanced antifibrinolytic activity |
| EP1809765A2 (en) * | 2004-11-04 | 2007-07-25 | Roche Diagnostics GmbH | Classification of acute myeloid leukemia |
| US20070178503A1 (en) * | 2005-12-19 | 2007-08-02 | Feng Jiang | In-situ genomic DNA chip for detection of cancer |
-
2004
- 2004-06-02 GB GBGB0412301.4A patent/GB0412301D0/en not_active Ceased
-
2005
- 2005-06-02 ZA ZA200610644A patent/ZA200610644B/en unknown
- 2005-06-02 CA CA002568889A patent/CA2568889A1/en not_active Abandoned
- 2005-06-02 CN CN200580026265.8A patent/CN101027410A/zh active Pending
- 2005-06-02 NZ NZ551797A patent/NZ551797A/en not_active IP Right Cessation
- 2005-06-02 DE DE602005025633T patent/DE602005025633D1/de active Active
- 2005-06-02 AP AP2006003862A patent/AP2006003862A0/xx unknown
- 2005-06-02 SI SI200531251T patent/SI1766056T1/sl unknown
- 2005-06-02 JP JP2007514130A patent/JP5060945B2/ja not_active Expired - Fee Related
- 2005-06-02 AU AU2005250219A patent/AU2005250219B2/en not_active Ceased
- 2005-06-02 WO PCT/GB2005/002180 patent/WO2005118851A1/en active Application Filing
- 2005-06-02 US US11/628,300 patent/US8105773B2/en not_active Expired - Fee Related
- 2005-06-02 AT AT05747218T patent/ATE493511T1/de not_active IP Right Cessation
- 2005-06-02 DK DK05747218.5T patent/DK1766056T3/da active
- 2005-06-02 ES ES05747218T patent/ES2358910T3/es active Active
- 2005-06-02 EP EP05747218A patent/EP1766056B1/en active Active
-
2006
- 2006-12-20 NO NO20065939A patent/NO20065939L/no not_active Application Discontinuation
-
2012
- 2012-01-05 US US13/344,088 patent/US20120295800A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| NZ551797A (en) | 2010-03-26 |
| JP2008501332A (ja) | 2008-01-24 |
| AU2005250219A1 (en) | 2005-12-15 |
| US20120295800A1 (en) | 2012-11-22 |
| AU2005250219B2 (en) | 2011-01-20 |
| SI1766056T1 (sl) | 2011-05-31 |
| EP1766056B1 (en) | 2010-12-29 |
| ATE493511T1 (de) | 2011-01-15 |
| CA2568889A1 (en) | 2005-12-15 |
| US8105773B2 (en) | 2012-01-31 |
| DE602005025633D1 (ja) | 2011-02-10 |
| JP5060945B2 (ja) | 2012-10-31 |
| DK1766056T3 (da) | 2011-03-14 |
| GB0412301D0 (en) | 2004-07-07 |
| US20080026385A1 (en) | 2008-01-31 |
| WO2005118851A1 (en) | 2005-12-15 |
| CN101027410A (zh) | 2007-08-29 |
| AP2006003862A0 (en) | 2006-12-31 |
| EP1766056A1 (en) | 2007-03-28 |
| ES2358910T3 (es) | 2011-05-16 |
| NO20065939L (no) | 2007-02-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA200610644B (en) | Oligonucleotides for cancer diagnosis | |
| Hodge et al. | Conserved cell types with divergent features in human versus mouse cortex | |
| US10697975B2 (en) | Methods for identifying, diagnosing, and predicting survival of lymphomas | |
| CN105917008B (zh) | 用于前列腺癌复发的预后的基因表达面板 | |
| US20020187480A1 (en) | Diagnostic method for assessing a condition of a performance animal | |
| KR20180123020A (ko) | 카피수 변이를 판정하기 위한 dna 단편 크기의 사용 | |
| US20170096713A1 (en) | Applications of single molecule sequencing | |
| US20060057608A1 (en) | Producing, cataloging and classifying sequence tags | |
| CN107771221A (zh) | 用于癌症筛查和胎儿分析的突变检测 | |
| EP2121988B1 (en) | Prostate cancer survival and recurrence | |
| WO2011086174A2 (en) | Diagnostic gene expression platform | |
| CN109679957B (zh) | IncRNALNC_004208及其检测试剂在制备脑胶质瘤预后试剂中的应用 | |
| Kim et al. | Single-cell transcriptomics: a novel precision medicine technique in nephrology | |
| Liehr | Cytogenetics and molecular cytogenetics | |
| US20180051342A1 (en) | Prostate cancer survival and recurrence | |
| Chang et al. | Microarray analysis of stem cells and differentiation | |
| ZA200503797B (en) | Product and method | |
| AU2007277142B2 (en) | Methods for identifying, diagnosing, and predicting survival of lymphomas | |
| Cattelan | Development of a NGS workflow for diagnostic applications in oncology | |
| CN114517232A (zh) | 无创方式判断子宫内膜容受性的方法、模型和标志物 |